1999
DOI: 10.1016/s0024-3205(99)00126-5
|View full text |Cite
|
Sign up to set email alerts
|

5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
55
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(70 citation statements)
references
References 21 publications
15
55
0
Order By: Relevance
“…after the last stimulation, cardioaccelerator or vasopressor responses were elicited by giving i.v. bolus injections of exogenous noradrenaline (0.03, 0.1, 0.3, 1 and 3 μg/kg), as reported earlier .…”
Section: Methodsmentioning
confidence: 83%
“…after the last stimulation, cardioaccelerator or vasopressor responses were elicited by giving i.v. bolus injections of exogenous noradrenaline (0.03, 0.1, 0.3, 1 and 3 μg/kg), as reported earlier .…”
Section: Methodsmentioning
confidence: 83%
“…The simplest interpretation of these findings suggests that the cardioaccelerator sympathetic outflow in diabetic (as compared to normoglycaemic) rats involves a differential activation of α 2 ‐adrenergic, dopamine D 2 ‐like and histamine H 3 /H 4 receptors. Admittedly, we did not measure directly the release of noradrenaline from sympathetic nerves, but it was determined indirectly by assessment of the evoked tachycardic responses induced by sympathetic stimulation, as previously reported . In this respect, it is noteworthy that, unlike exogenous noradrenaline given i.v., sympathetic nerves can release, in addition to noradrenaline, several co‐transmitters including neuropeptide Y, ATP, galanin, etc.…”
Section: Discussionmentioning
confidence: 97%
“…[21][22][23] Previous studies performed in our laboratory have revealed the existence of different serotonergic mechanisms that increase or inhibit sympathetic vascular and cardiac neurotransmission. These mechanisms involve a decrease in the release of noradrenaline through the activation of presynaptic 5-HT1 receptors 14,17,24 or increases in noradrenaline levels as a result of 5-HT3 receptor activation. 14 The possible interaction between the above two systems has been also investigated by our group in mesenteric and renal autoperfused vascular beds (E Calama et al, unpubl.…”
Section: Discussionmentioning
confidence: 99%